T0	Interventions 47 56	docetaxel
T1	Interventions 302 312	docetaxel.
T2	Interventions 469 627	randomized to receive nab-paclitaxel 300 mg/m(2) q3w, nab-paclitaxel 100 mg/m(2) or 150 mg/m(2) the first 3 of 4 weeks (qw 3/4), or docetaxel 100 mg/m(2) q3w.
T3	Interventions 929 938	docetaxel
T4	Interventions 1213 1222	docetaxel
T5	Interventions 1369 1379	docetaxel.